Trial Search Results

Targeted Therapy of Bronchiolitis Obliterans Syndrome

This phase II trial studies how well giving fluticasone propionate, azithromycin, and montelukast sodium (FAM) together works in treating patients with bronchiolitis obliterans who previously underwent stem cell transplant. FAM may be an effective treatment for bronchiolitis obliterans

Stanford is currently not accepting patients for this trial.